Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019 - Yahoo Finance

Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019  Yahoo Finance

Affimed N.V. (AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced the ...



Comments

Popular posts from this blog

Keto crotch: Is it real and how to treat it

Shave your pubic hair if you want, but not at these times